Kim Kyung Hyun, Shim Youngbo, Lee Ji Yeoun, Phi Ji Hoon, Koh Eun Jung, Kim Seung-Ki
Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul, Korea.
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
J Korean Neurosurg Soc. 2023 Mar;66(2):162-171. doi: 10.3340/jkns.2022.0089. Epub 2023 Feb 10.
The goal of this study was to analyze the clinical outcomes of endoscopic third ventriculostomy (ETV) and endoscopic septostomy when shunt malfunction occurs in a patient who has previously undergone placement of a ventriculoperitoneal shunt.
From 2001 to 2020 at Seoul National University Children's Hospital, patients who underwent ETV or endoscopic septostomy for shunt malfunction were retrospectively analyzed. Initial diagnosis (etiology of hydrocephalus), age at first shunt insertion, age at endoscopic procedure, magnetic resonance or computed tomography image, subsequent shunting data, and follow-up period were included.
Thirty-six patients were included in this retrospective study. Twenty-nine patients, 18 males and 11 females, with shunt malfunction underwent ETV. At the time of shunting, the age ranged from 1 day to 15.4 years (mean, 2.4 years). The mean age at the time of ETV was 13.1 years (range, 0.7 to 29.6 years). Nineteen patients remained shunt revision free. The 5-year shunt revisionfree survival rate was 69% (95% confidence interval [CI], 0.54-0.88). Seven patients, three males and four females, with shunt malfunction underwent endoscopic septostomy. At the time of shunting, the age ranged from 0.2 to 12 years (mean, 3.9 years). The mean age at the time of endoscopic septostomy was 11.9 years (range, 0.5 to 29.5 years). Four patients remained free of shunt revision or addition. The 5-year shunt revision-free survival rate was 57% (95% CI, 0.3-1.0). There were no complications associated with the endoscopic procedures.
The results of our study demonstrate that ETV or endoscopic septostomy can be effective and safe in patients with shunt malfunction.
本研究的目的是分析在先前接受过脑室腹腔分流术的患者出现分流故障时,内镜下第三脑室造瘘术(ETV)和内镜下隔膜造瘘术的临床结果。
对2001年至2020年在首尔国立大学儿童医院因分流故障接受ETV或内镜下隔膜造瘘术的患者进行回顾性分析。纳入初始诊断(脑积水病因)、首次分流置入时的年龄、内镜手术时的年龄、磁共振或计算机断层扫描图像、后续分流数据以及随访期。
本回顾性研究纳入了36例患者。29例因分流故障的患者(18例男性和11例女性)接受了ETV。分流时,年龄范围为1天至15.4岁(平均2.4岁)。ETV时的平均年龄为13.1岁(范围0.7至29.6岁)。19例患者无需进行分流修正。5年无分流修正生存率为69%(95%置信区间[CI],0.54 - 0.88)。7例因分流故障的患者(3例男性和4例女性)接受了内镜下隔膜造瘘术。分流时,年龄范围为0.2至12岁(平均3.9岁)。内镜下隔膜造瘘术时的平均年龄为11.9岁(范围0.5至29.5岁)。4例患者无需进行分流修正或追加手术。5年无分流修正生存率为57%(95% CI,0.3 - 1.0)。内镜手术未出现相关并发症。
我们的研究结果表明,ETV或内镜下隔膜造瘘术对于分流故障患者可能是有效且安全的。